Bologna, Italy

Luigi Fiume

This inventor holds 6 USPTO granted patents and 1 EPO patent. Top assignees: Laboratori Baldacci S.p.a., Laboratori Balducci S.p.a., Alma Mater Studiorum-Universitá Di Bologna. Active years: 1988-2009.


% Patents Active = 83.3


Average Co-Inventor Count = 4.0

ph-index = 2

Forward Citations = 15(Granted Patents)


Location History:

  • Pisa, IT (2001)
  • Bologna, IT (1988 - 2009)

Company Filing History:


Years Active: 1988-2009

Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: Luigi Fiume: Innovator in Pharmaceutical Conjugation

Introduction

Luigi Fiume is a notable inventor based in Bologna, Italy, recognized for his contributions to the field of pharmaceutical conjugation. With a total of six patents to his name, Fiume has made significant advancements in drug delivery systems, particularly in the area of antiviral drugs.

Latest Patents

Fiume's latest patents include a process for the preparation of doxorubicin conjugates with lactosaminated human albumin. This innovative procedure involves conjugating hydrazone derivatives of doxorubicin to lactosaminated human albumin using trialkylphosphines. This method offers advantages over traditional thiol reducing agents, as it simplifies the process and avoids the formation of precipitates. Another significant patent involves hepatotropic conjugates of antiviral drugs, detailing methods for creating these compounds and their pharmaceutical compositions.

Career Highlights

Throughout his career, Fiume has worked with reputable companies such as Laboratori Baldacci S.p.a. and Laboratori Balducci S.p.a. His work has focused on enhancing the efficacy of antiviral drugs through innovative conjugation techniques.

Collaborations

Fiume has collaborated with notable professionals in his field, including Corrado Busi and Alessandro Mattioli. These partnerships have contributed to the development of his groundbreaking inventions.

Conclusion

Luigi Fiume's work in pharmaceutical conjugation has paved the way for advancements in drug delivery systems. His innovative approaches continue to influence the field and improve therapeutic outcomes for patients.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…